Voyager Therapeutics, Inc. ·

VYGR 8-K 2026-07-13

Voyager Therapeutics, Inc. (VYGR) 8-K dated 2026-07-13 — accession 0001104659-26-082906. This URL is the filing, not the VYGR hub.

Voyager Therapeutics, Inc. (VYGR) is a biotechnology company listed on NASDAQ.

Voyager Therapeutics, Inc. filed a 8-K on 2026-07-13. Accession 0001104659-26-082906.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.

Not investment advice. The VYGR SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR